Civitas Therapeutics to Present at JMP Securities Healthcare Conference
7/2/2013 9:35:12 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Civitas Therapeutics, Inc., a biopharmaceutical company with a lead program in Parkinson’s disease that leverages the ARCUS(TM) respiratory delivery platform, today announced that Glenn Batchelder, President and Chief Executive Officer, will present a corporate update at the JMP Securities Healthcare Conference in New York City on Tuesday, July 9, 2013 at 4:30 p.m. (EDT).
Help employers find you! Check out all the jobs and post your resume.
comments powered by